Skip to main content
Library homepage
 

Text Color

Text Size

 

Margin Size

 

Font Type

Enable Dyslexic Font
Medicine LibreTexts

19: Riboflavin (Chapter 20b)

( \newcommand{\kernel}{\mathrm{null}\,}\)

Abstract

Ribo­flavin is a component of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which act as coenzymes of different flavo­proteins involved in oxidation-reduction reactions that are central to energy production, intermediary metab­olism, drug metab­olism and the maintenance of anti­oxidant status. Ribo­flavin coenzymes are also required for the metab­olism of folate, vitamin B12, vitamin B6, and niacin as well as for mobilization of iron from intracellular stores. Classical signs of ribo­flavin deficiency (aribo­flavinosis) generally occur in association with other nutrient deficiencies, notably vitamin B6. Ribo­flavin deficiency has been described predominantly in undernourished populations in low income countries, but accumulating evidence has shown that a suboptimal ribo­flavin status is more common than previously recognized among populations in developed countries. Measurement of the activity of glutathione reductase, with and without the prosthetic group FAD, is the best method for assessing tissue ribo­flavin status, particularly in cases of impaired ribo­flavin status. The test measures tissue saturation and long-term ribo­flavin status, although some confounding factors may influence its performance. Urinary ribo­flavin excretion levels in casual or 24h urine specimens reflect dietary intake but vary widely because concen­trations are affected by many non-nutritional factors. Concen­trations of ribo­flavin, FMN and FAD in plasma or erythrocytesG as well as measurement of the activity of pyri­dox­amine phosphate oxidase and its activity coefficient appear promising options for assessment of ribo­flavin status and warrant further exploration.

  • 19.1: Riboflavin (20b.1)
    This page discusses riboflavin, essential for energy metabolism and as a precursor for important coenzymes. Deficiency, known as ariboflavinosis, can cause various symptoms and is more likely in at-risk populations such as undernourished women and children. Certain medications and genetic factors can affect riboflavin bioavailability, leading to health risks like hypertension. Dietary sources include dairy and meat, with plant-based diets being more deficient.
  • 19.2: Biomarkers of ribo­flavin status (20b.2)
    This page discusses the challenges in diagnosing riboflavin deficiency, emphasizing the use of the erythrocyte glutathione reductase activity coefficient (EGR AC) for long-term status assessment. However, sensitivity issues and variations in laboratory methods complicate prevalence comparisons. Riboflavin status is further explored through urinary excretion metrics, with different assays showing discrepancies.


This page titled 19: Riboflavin (Chapter 20b) is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by Rosalind S. Gibson via source content that was edited to the style and standards of the LibreTexts platform.

Support Center

How can we help?